Dr. Wei Song, MD, PhD

Dr. Song practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Song's NPI, 1306164157, was assigned on May 4, 2010. Dr. Song graduated from Shanghai Medical University in 1993. Dr. Song holds California license C176113.

Dr. Song's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Song's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Song is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Song to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices, 3 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Song is board certified in pathology - anatomic by the American Board of Pathology. Dmand AI has Dr. Song's licenses on file in 5 states: California, Alabama, New York, Massachusetts and Illinois.

CMS data shows 422 Medicare services from Dr. Song across 1 procedure code in 2024, for 327 Medicare patients. Medicare paid $16,084 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 327 Medicare patients who saw Dr. Song in 2024. The largest group is 65 to 74, with 142 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 61, with 52% women.

In 2024, Dr. Song wrote 16 Medicare Part D claims. 94% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Song for performance year 2024, reported as part of a group. Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 108 papers to Dr. Song, published from 2007 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Drosophila Proteins, Cell Proliferation and China. Dr. Song has published most often in Sci Total Environ. Dr. Song's most frequent co-authors are Wei Song, MD, David C. Markel, MD and Theresa C. Scognamiglio, MD.

CMS Open Payments shows 17 general payments to Dr. Song from 5 drug and device companies from 2017 to 2024. Speaker and faculty fees make up the largest share, 59% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $8,156.

Dr. Song graduated from Shanghai Medical University in 1993.

Dr. Song is in network with 5 carriers, including Excellus BlueCross BlueShield, Molina and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.